The role of CRP and ATG9B expression in clear cell renal cell carcinoma
Open Access
- 15 November 2017
- journal article
- retracted article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 37 (6)
- https://doi.org/10.1042/bsr20171082
Abstract
The purpose of the study is to investigate the correlation between the expression of C-reactive protein (CRP) and autophagy-related 9B (ATG9B) and pathological features of clear cell renal cell carcinoma (CCRCC) patients. We also intended to explore the effects of manipulated expression of CRP and ATG9B on the apoptosis and cell cycle progression of CCRCC cell line. ATG9B expression in CCRCC tissues and adjacent renal tissues was analyzed by immunohistochemistry (IHC). Gene expression was determined at transcription and translational levels using real-time quantitative PCR (RT-qPCR) and Western blot. The association between CRP/ATG9B expression and clinical-pathological parameters including age, gender, pathological grades, TNM stage and distant metastasis of the patients was assessed by correlation analysis. siRNA and overexpression plasmids construction were used to manipulate the expression of CRP in human CCRCC cell line 786-O. Cell apoptosis and cell cycle progression were determined using flow cytometry (FCM) and Hoechst 33258 staining. CRP expression correlates with ATG9B expression. The expression of CRP and ATG9B are significantly correlated with TNM staging, distant metastasis, and survival time of CCRCC patients. A high-level of CRP indicates a poor overall survival (OS). In addition, CRP expression influences cell cycle and apoptosis of CCRCC cells. The study reveals that CRP might be a CCRCC development promoter. In addition, there is a close relationship between CRP and ATG9B in CCRCC carcinogenesis.Keywords
This publication has 36 references indexed in Scilit:
- Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case ReportThe American Journal of Case Reports, 2017
- Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinomaBritish Journal of Cancer, 2016
- Cytology diagnosis of metastatic clear cell renal cell carcinoma, synchronous to pancreas, and metachronous to thyroid and contralateral adrenal: Report of a case and literature reviewDiagnostic Cytopathology, 2016
- Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinomaOncoTargets and Therapy, 2016
- C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewPLOS ONE, 2015
- Cross-cancer profiling of molecular alterations within the human autophagy interaction networkAutophagy, 2015
- Targeting Ions-Induced Autophagy in CancerCancer Cell, 2014
- Biology and trafficking of ATG9 and ATG16L1, two proteins that regulate autophagosome formationFEBS Letters, 2013
- The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcomaEuropean Journal of Cancer, 2013
- Frameshift mutations of autophagy‐related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instabilityThe Journal of Pathology, 2008